Wojciech B.
- Country
- Poland
- Department
- N/A
Research Overview
- Phase III Randomized Double‑Blind Study of Fenebrutinib versus Teriflunomide for Efficacy and Safety in Adults with Relapsing Multiple Sclerosis
- A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of NAV-240 in Adults with Moderate-to-Severe Hidradenitis Suppurativa
- Efficacy and Safety of Guselkumab Versus Etanercept in Pediatric Chronic Plaque Psoriasis: A Randomized, Placebo-Controlled Phase 3 Trial
Data & Insights
Has run more than one trial at 342 of 640 partner sites.
Specializations
Psoriasis Research
This investigator specializes in treating moderate to severe plaque psoriasis, with particular attention to both adult and pediatric populations. Their research encompasses chronic plaque psoriasis management and innovative therapeutic approaches.
- Adult plaque psoriasis treatments
- Pediatric psoriasis interventions
- Special area psoriasis management
Dermatological Conditions
The investigator focuses on complex dermatological disorders, particularly atopic dermatitis and hidradenitis suppurativa. Their work includes evaluation of novel therapeutic agents for these challenging conditions.
- Moderate to severe atopic dermatitis
- Pediatric dermatology treatments
- Inflammatory skin conditions
Associated Conditions
The investigator's expertise extends to related conditions including psoriatic arthritis and alopecia areata. Their research involves investigating treatments for patients with varying response levels to conventional therapies.
- Biologic therapy applications
- Treatment-resistant cases
- Long-term therapeutic outcomes
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.